Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Vasculitis: early-phase trial registry
7 of 12 indexed Vasculitis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 7 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Vasculitis: 12 US clinical trials tracked, 7 recruiting.
Vasculitis is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Allergy and Infectious Diseases (NIAID), running 3 of these trials.
Enrollment posture brief
Registry condition vasculitis
OPEN 7 | RECR 58% | LATE 2 | EARLY 5 | RANK #1429 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Anterior Cruciate Ligament Reconstruction (58% recruiting · 12 trials)
Vasculitis lists 7 open slots (58% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Vasculitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Vasculitis is recruiting above its size-band peers.
7 of 12 indexed trials (58.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Vasculitis research.
National Institute of Allergy and Infectious Diseases (NIAID) accounts for 3 of 12 trials (25%). 8 distinct sponsors appear on at least one study for this condition label.
-
Most Vasculitis trials plan to enrol fewer than 100 people.
Median target enrolment is 50 among the 12 trials that report a genuine target (sentinel values excluded). 9 of those (75%) plan for fewer than 100 participants.
-
Vasculitis splits between interventional and observational designs.
7 interventional and 5 observational studies make up this index (58.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
A Real-World Registry of Chronic Wounds and Ulcers
U.S. Wound Registry
NCT02280733
Longitudinal Study for Relapsing Polychondritis
University of Pennsylvania
NCT04919538
Vasculitis Pregnancy Registry
University of Pennsylvania
NCT02593565
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Peter Merkel
NCT03004326
Longitudinal Study for Central Nervous System Vasculitis
University of Pennsylvania
NCT05734404
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
Amgen
NCT06321601
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
University of California, San Francisco
NCT02638701
The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
University of South Florida
NCT01933724
Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00004567
Etanercept to Treat Wegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001901
Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
National Heart, Lung, and Blood Institute (NHLBI)
NCT00005928
Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001761
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Vasculitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Vasculitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Vasculitis page
12 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Vasculitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most Vasculitis trials on record, review their full trial history before evaluating a specific study. See National Institute of Allergy and Infectious Diseases (NIAID)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vasculitis condition card totals 12 registered trials; most-linked intervention Interleukin-10; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.